Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VolitionRX Ltd VNRX

Healthcare Medical Instruments & Supplies
VolitionRx Limited is a multi-national epigenetics company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and... see more

Recent & Breaking News (NYSEAM:VNRX)

VolitionRx Sells First NuQ® Research Use Only Kits to Active Motif

PR Newswire June 23, 2014

VolitionRx Appoints Dr. Habib Skaff to Board of Directors

Marketwired June 3, 2014

VolitionRx Announces First Published Data in Anticancer Research Journal

Marketwired April 30, 2014

VolitionRx Extends Agreement With University Hospital Bonn to Include CE Mark Performance Evaluation

Marketwired April 24, 2014

VolitionRx Extends Agreement With University Hospital Bonn to Include CE Mark Performance Evaluation

Marketwired April 24, 2014

President and CEO of VolitionRx Issues Corporate Update

Marketwired April 2, 2014

President and CEO of VolitionRx Issues Corporate Update

Marketwired April 2, 2014

New VolitionRx Study Data Demonstrates NuQ(R) Assays' High Detection Rate of Prostate Cancer and the Ability to Distinguish Between Prostate and Colorectal Cancer

Marketwired March 17, 2014

VolitionRx Completes $3 Million Private Placement

Marketwired February 28, 2014

VolitionRx Commences First Large Clinical Trial in Collaboration With Hvidovre Hospital, Denmark

Marketwired January 22, 2014

VolitionRx Presents at MicroCapClub Invitational

Marketwired January 9, 2014

MissionIR Releases Exclusive Audio Interview With VolitionRx Ltd. (VNRX) CEO Cameron Reynolds

Marketwired January 7, 2014

VolitionRx Announces Engagement of MissionIR Investor Relations Services

Marketwired December 23, 2013

VolitionRx Finds Simple Blood Test Detects 85% of Colorectal Cancers and Over 50% of Polyps

PR Newswire December 2, 2013

VolitionRx to Present at the 6th Annual LD Micro Conference

PR Newswire November 29, 2013

VolitionRx Expands Sample Size to 11,000 in Pivotal Colorectal Cancer Trial with Hvidovre Hospital, Denmark

PR Newswire November 14, 2013

VolitionRx and Active Motif enter into Distribution Agreement for Volition's Research Use Only ELISA Kits

PR Newswire September 26, 2013

VolitionRx-led Consortium Awarded euro 780 000 ($1M approx.) Eurostars Grant

PR Newswire September 3, 2013

VolitionRx to use Innova Biosciences' Biotin Technology in its Epigenetic Research Kits

PR Newswire July 22, 2013

Equities.com Announces Exclusive and Unique Video Interviews

Globe Newswire June 12, 2013